首页> 外文期刊>Frontiers in Immunology >Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes
【24h】

Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes

机译:缺少564Igi中的体细胞超突变的加速的全身性自身免疫:敲入重链和轻链基因的系统性狼疮的小鼠模型。

获取原文
           

摘要

564Igi mice have knocked-in immunoglobulin (Ig) heavy (H) and light (L) chain genes that encode an autoantibody recognizing RNA. Previously, we showed that these mice produce pathogenic IgG autoantibodies when activation-induced deaminase (AID) is expressed in pre-B and immature B cells but not when it is expressed only in mature B cells. AID has two functions; it is necessary for somatic hypermutation (SHM) and class switch recombination (CSR). To determine the role of each of these functions in the generation of pathogenic autoantibodies, we generated 564Igi mice that carry a mutant AID-encoding gene, Aicda ( Aicda ~(G23S)), which is capable of promoting CSR but not SHM. We found that 564Igi Aicda ~(G23S)mice secreted class-switched antibodies (Abs) at levels approximately equal to 564Igi mice. However, compared to 564Igi mice, 564Igi Aicda~( G23S ) mice had increased pathogenic IgG Abs and severe systemic lupus erythematosus-like disease, including, glomerulonephritis, and early death. We suggest that in 564Igi mice SHM by AID changes Ig receptors away from self reactivity, thereby mitigating the production of autoantibody, providing a novel mechanism of tolerance.
机译:564Igi小鼠具有敲入的免疫球蛋白(Ig)重链(H)和轻链(L)链基因,它们编码识别自身抗体的RNA。以前,我们表明当激活诱导的脱氨酶(AID)在前B细胞和未成熟B细胞中表达而在仅在成熟B细胞中表达时,这些小鼠会产生致病性IgG自身抗体。 AID具有两个功能;体细胞超突变(SHM)和类开关重组(CSR)是必需的。为了确定每种功能在致病性自身抗体生成中的作用,我们生成了564Igi小鼠,它们携带突变型AID编码基因Aicda(Aicda〜(G23S)),该基因能够促进CSR但不能促进SHM。我们发现564Igi Aicda〜(G23S)小鼠分泌的类转换抗体(Abs)大约等于564Igi小鼠。但是,与564Igi小鼠相比,564Igi Aicda(G23S)小鼠的病原性IgG Abs增多,并出现严重的系统性红斑狼疮样疾病,包括肾小球肾炎和早期死亡。我们建议在564Igi小鼠中,通过AID的SHM改变了Ig受体的自身反应性,从而减轻了自身抗体的产生,提供了一种新的耐受机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号